| 摘要 |
Novel selenophene compounds useful as anti-tumor agents are described. Preferred compounds include compounds of formula I: wherein R<SUB>1 </SUB>and R<SUB>2 </SUB>are independently selected from the group consisting of H, CHO, CH<SUB>2</SUB>OH and CH<SUB>2</SUB>NH<SUB>2</SUB>; and X and Y are independently selected from the group consisting of Se, S, O, NCH<SUB>3</SUB>, and NH. Pharmaceutical compositions and a method for treating patients having tumors utilizing the disclosed selenophene compounds are also described.
|
